Novartis reveals new hope with overall survival benefit for HR+/HER2- advanced breast cancer patients
“Breast cancer is the most common form of cancer among Egyptian women…
Breakthrough treatment from Novartis sparks new hope for HR+/HER2- advanced breast cancer patients
“Breast cancer is the most common form of cancer among Egyptian women,…
Novartis Egypt launches campaign to address critical risk of high blood cholesterol
46% of deaths in country caused by cardiovascular disease
Novartis remains committed to supporting Egypt’s COVID-19 fight
Pharmaceutical company announces formation of $40m global Novartis COVID-19 Response Fund
Novartis launches ‘Oncology On Air’ campaign for raising awareness on breast cancer
Breast cancer responsible for about 15% of deaths of tumours
Sales of pharmaceutical companies increase by EGP 10bn, growing by 31%
Factories’ revenues amounted to EGP 5bn in November, despite calls for raising…
Generic drug competition hits Novartis sales
The Swiss pharmaceutical giant Novartis has said its net profit slipped 3…
